Wipro GE Healthcare's 'Made in India' AI-driven Cath Lab for Advanced Cardiac Care

An AI-powered "Made in India" Cath Lab-Optima IGS 320 has been introduced by GE Healthcare, a medical technology, diagnostics, and digital solutions company, to advance cardiac care in India.

Cath Lab-Optima utilizes the GE-exclusive AutoRight technology and is constructed at the brand-new Bengaluru factory of Wipro GE Healthcare. The company claims that AutoRight is the first interventional image chain based on neural networks. It highlights artificial intelligence that consequently streamlines images and dose parameters in real time, empowering clinicians to therefore focus on patients.

According to Dr. Shravan Subramanyam, managing director of Wipro GE Healthcare, the increasing complexity of patient profiles and the shifting patterns of disease are increasing the importance of personalized care. The patient care pathway could be changed in ways that are based on AI-based solutions.

Non-communicable diseases (NCDs) account for 60% of all deaths in India, with cardiovascular diseases (CVDs), chronic respiratory diseases, cancer, and diabetes accounting for 82%.

It supports intelligent and precise healthcare delivery by allowing visualization across imaging and is intended for cardiac and electrophysiology procedures. The Cath lab also improves the quality of the images, which may help doctors perform complex procedures with confidence and reduce complications by allowing them to place stents with greater precision.

Prior in 2022, Wipro GE Medical services had likewise introduced Revolution Aspire CT (Computed Tomography) scanner. It was launched at the Medical Devices Manufacturing plant of the company and was the company's first product to be designed and manufactured entirely in India.